If this was just one out of ten investments for you, you probably wouldn’t feel the need to check in here often or worry too much. But when you’re heavily invested in a stock that’s been stuck waiting for an MHRA decision for over a year, it’s only natural to feel uncertain. Your emotions shift over time, and eventually, the prolonged silence can lead to pessimism. In my view, pumping is actually worse than bashing. While bashing might hurt the company's reputation or chances of success, pumping can mislead investors—and let’s be honest, companies can recover more easily than individual investors can.
Market Data 
Markets 
AI
